NEW ORLEANS – The American Academy of Ophthalmology’s Intelligent Research in Sight Registry is a useful tool for managing the difficulty cornea and external disease practices may face in the wake of the Affordable Care Act, according to a speaker here.
“Simplify where possible,” David B. Glasser, MD, said here at Cornea Subspecialty Day preceding the American Academy of Ophthalmology meeting. “The academy’s IRIS [Intelligent Research in Sight] Registry is a great way to do that if you’ve got a long-term health record.”
The American Academy of Ophthalmology describes the registry as a comprehensive eye disease database designed to help ophthalmologists improve the quality of care they provide. The centralized collection and reporting tool processes data from electronic health records, allowing providers to analyze their own care, compare it to that of other providers and identify areas for improvement.
Glasser also advised attendees to analyze their payer and fee schedules.
“That’s nothing new,” he said. “And you’ll have to read your contracts again. Tell your ambulatory surgery centers to analyze their contracts so they don’t get surprised with potential tissue payment issues.”
Disclosure: Glasser has no relevant financial interests.